These injectable drugs suppress appetite and regulate blood sugar to promote weight loss in patients with obesity or diabetes
However, many insurance companies do not cover weight loss medications such as Wegovy and Zepbound when used solely for weight reduction
Neurological changes and food relationship GLP-1 receptors in the brain are concentrated in areas that regulate appetite, reward, and impulse control
When semaglutide activates GLP-1 receptors on pancreatic beta cells, those cells immediately sense blood glucose levels more acutely and release insulin only when glucose is elevatedpreventing the harmful blood sugar spikes that occur after meals
New research might add safety tips or reveal new risks, so keeping up to date keeps care safe and smart
After submitting your health history, our qualified providers evaluate your eligibility for GLP-1 medications